There has been much said in the news lately about the opioid crisis. When Donald Trump made his speech last month about the issue, you’d think he discovered the problem. Well, that’s only about 180 degrees off the mark.
The opioid problem in the United States has been recognized by experts in the field for years. And it was his predecessor, President Obama, who first issued a proclamation declaring “Prescription Opioid and Heroin Epidemic Awareness Week.” Prior to that proclamation, Obama proposed a $1.1 billion funding initiative to address the issue. Now President Trump comes along, and of course with great fanfare, announces that there’s a problem. No new funding. What he did in his speech was to point the finger at Chinese drug traffickers, mention in passing increased training by the manufacturers of drugs, and going after those who illegally prescribe drugs.
These are, in all fairness, issues that should be addressed. But what is sorely lacking in the speech is any notion that the drug manufacturers themselves have had a huge role in creating and maintaining the epidemic. Interestingly, he announced an “ambitious” partnership with pharmaceutical manufacturers to develop non-addictive painkillers and new overdose treatments. But does this really reach the heart of the problem?
Here are some of the allegations concerning the role of the pharmaceutical companies in fueling the opioid epidemic:
So, what does this all mean? As an example, according to the DEA, the “Big Three” (that’s the group of the three largest prescription drug makers in the Unites States) pumped enough hydrocodone and oxycodone into the state of West Virginia over a period of six years to provide 235 pills for every person (including children) who live in the state. Opioid overdoses led to 1,700 deaths in the state during that same period.
What the problem needs is a solution. One aspect is to provide money to fund the FDA, so it has enough resources to review the ads that the drug makers are using. Another is to provide funds for treatment, not just talk about it. And finally, and perhaps more importantly, to go after the drug manufacturers who really are the source of the problem. In this regard, one of the Big Three, McKesson Corporation, settled claims that it failed to report hundreds of suspicious orders which it received from online pharmacies, and which fueled an explosion of the prescription drug problem. The settlement cost McKesson $13.25 million. Since McKesson’s revenue is almost $200 billion annually, that would be like a millionaire paying about $65 to settle a fraud/death claim. Not much of an incentive, is it!
The Feldman Law Firm PLLC
1 E. Washington Street
Phoenix, AZ 85004
The Feldman Law Firm, PLLC has merged with The Law Office of Bret A. Royle for form Feldman Royle, Attorneys at Law, PLLC. Adam Feldman will still remain the sole attorney of record for all cases retained under The Feldman Law Firm, PLLC.
The Feldman Law Firm is located in Phoenix, Arizona and provides criminal defense throughout the state of Arizona. This website is not intended to create a client attorney relationship, nor does communication though this website. This website is for marketing purposes only.